Etymologia: Rifampin

Etymologia: Rifampin

Bibliographic Details
Main Author:	Ronnie Henry
Format:	Article
Language:	English
Published:	Centers for Disease Control and Prevention 2018-03-01
Series:	Emerging Infectious Diseases
Subjects:	rifampin rifampicin rifamycin drugs Rififi tuberculosis
Online Access:	https://wwwnc.cdc.gov/eid/article/24/3/et-2403_article

Similar Items

In Vitro Activity of Rifampin, Rifabutin, and Rifapentine against Enterococci and Streptococci from Periprosthetic Joint Infection
by: Mariana Albano, et al.
Published: (2021-09-01)

Tuberculosis-HIV treatment with rifampicin or rifabutin: are the outcomes different?
by: Carolina Arana Stanis Schmaltz, et al.
Published: (2019-02-01)

Evaluation of GeneXpert Mycobacterium tuberculosis/Rifampin for the detection of Mycobacterium tuberculosis complex and rifampicin resistance in nonrespiratory clinical specimens
by: Maya Habous, et al.
Published: (2019-01-01)

Drug Resistance in Mycobacterium Tuberculosis Isolates to Isoniazid and Rifampin
by: M Pourhajibagher, et al.
Published: (2012-05-01)

Investigation of Rifampin Serum Levels in Patients Diagnosed with Tuberculosis Treated with the Drug Regimen Mazandaran, 2020-2021
by: Lotfollah Davoodi, et al.
Published: (2023-11-01)

The molecular basis of resistance to isoniazid, rifampin, and pyrazinamide in <it>Mycobacterium tuberculosis</it>
by: Parsons Linda M, et al.
Published: (2001-04-01)

Assessment of adherence to antituberculosis drug regimen among patients receiving isoniazid, rifampin and pyrazinamide: Kerman, Iran
by: Seyyed Mojtaba Sohrevardi, et al.
Published: (2019-07-01)

Identifying Mycobacterium Tuberculosis Resistance to Rifampin by Multiplex Specific PCR Method
by: F Din Mohammadi, et al.
Published: (2011-04-01)

Rifampin resistance among individuals with extrapulmonary tuberculosis: 4 years of experience from a reference laboratory
by: S. Baghbanbashi, et al.
Published: (2021-03-01)

Oral anticoagulants and concurrent rifampin administration in tuberculosis patients with non-valvular atrial fibrillation
by: Ki Won Hwang, et al.
Published: (2023-04-01)

State of the Art on Developments of (Bio)Sensors and Analytical Methods for Rifamycin Antibiotics Determination
by: Hassan Noor, et al.
Published: (2023-01-01)

rpoB Mutations and Effects on Rifampin Resistance in Mycobacterium tuberculosis
by: Li M, et al.
Published: (2021-10-01)

Evaluation of the frequency of resistance to 2 drugs (Isoniazid and Rifampin) by molecular investigation and it's risk factors in new cases of smear positive pulmonary tuberculosis in health centers under the cover of Jundishapur University of Medical Sciences in 2017
by: Shokrollah Salmanzadeh, et al.
Published: (2020-01-01)

Rifampin‐induced acute kidney injury and hemolysis: A case report and literature review of a rare condition
by: Fateen Ata, et al.
Published: (2022-12-01)

Identification of Mycobacterium tuberculosis and Rifampin Resistance in Pulmonary and Extra-pulmonary Clinical Specimens Using the Gene Xpert MTB/RIF Assay
by: Fahimeh Azadi, et al.
Published: (2021-07-01)

Evaluating newly approved drugs for multidrug-resistant tuberculosis (endTB): study protocol for an adaptive, multi-country randomized controlled trial
by: L. Guglielmetti, et al.
Published: (2021-09-01)

Silence as an element producer of moods/atmospheres in the film Rififi, by Jules Dassin
by: Diogo Rossi Ambiel Facini
Published: (2018-05-01)

Detection of rifampin-resistant genotypes in Mycobacterium tuberculosis by reverse hybridization assay
by: Raquel de A Maschmann, et al.
Published: (2011-03-01)

Deranged Haemostasis: Rifampin-Induced Coagulopathy
by: Raghu Tiperneni, et al.
Published: (2022-05-01)

Intestinal barrier function and serum concentrations of rifampin, isoniazid and pyrazinamide in patients with pulmonary tuberculosis
by: Mônica C. Façanha, et al.

Mycobacterium tuberculosis and Rifampin Resistance, United Kingdom
by: I-Ching Sam, et al.
Published: (2006-05-01)

rpoB Mutations are Associated with Variable Levels of Rifampin and Rifabutin Resistance in Mycobacterium tuberculosis
by: Li MC, et al.
Published: (2022-11-01)

Synergism of Linezolid and Rifampin to Combat Multidrug-Resistant Environmental Enterococci Isolates
by: Mobina Noori, et al.
Published: (2022-08-01)

Intestinal permeability and malabsorption of rifampin and isoniazid in active pulmonary tuberculosis
by: Valéria G. F. Pinheiro, et al.

How to Effectively Identify Patients With Rifampin-Resistant Tuberculosis in China: Perspectives of Stakeholders Among Service Providers
by: Qianhui Hua, et al.
Published: (2021-11-01)

Rifampin-divalproex drug-drug interaction in an adult patient: A case report
by: Christine Doran, PharmD, et al.
Published: (2021-01-01)

Characterization of rifampin-resistant Staphylococcus aureus nasal carriage in patients receiving rifampin-containing regimens for tuberculosis
by: Huang YT, et al.
Published: (2018-08-01)

Discordance in Mycobacterium tuberculosis Rifampin Susceptibility
by: Ameeta S. Kalokhe, et al.
Published: (2012-03-01)

Healthcare Provider Discrimination toward Pregnant Women with Rifampin-Resistant Tuberculosis
by: Marian Loveday, et al.
Published: (2019-03-01)

Influence of Rifamycin on Survival in Patients with Concomitant Lung Cancer and Pulmonary Tuberculosis
by: Ho-Sheng Lee, et al.
Published: (2023-11-01)

A model-based approach for a practical dosing strategy for the short, intensive treatment regimen for paediatric tuberculous meningitis
by: Roeland E. Wasmann, et al.
Published: (2023-04-01)

Not So Innocent: Thrombocytopenia After One Dose of Rifampicin
by: Tarana NAGIYEVA, et al.
Published: (2017-12-01)

Investigation of the rpoB Mutations Causing Rifampin Resistance by Rapid Screening in Mycobacterium Tuberculosis in North-East of Iran
by: Amir Tajbakhsh, et al.
Published: (2018-10-01)

Controversy about the Role of Rifampin in Biofilm Infections: Is It Justified?
by: Nora Renz, et al.
Published: (2021-02-01)

Molecular detection of rifampin, isoniazid, and ofloxacin resistance in Iranian isolates of Mycobacterium tuberculosis by high-resolution melting analysis
by: Sirous M, et al.
Published: (2018-10-01)

Molecular Identification of Mycobacterium tuberculosis and Analysis of Its Resistance to Rifampin in Sputa From Tuberculosis Suspected Patients
by: M. Syaifudin
Published: (2010-08-01)

Differential Impact of the rpoB Mutant on Rifampin and Rifabutin Resistance Signatures of Mycobacterium tuberculosis Is Revealed Using a Whole-Genome Sequencing Assay
by: Ming-Chih Yu, et al.
Published: (2022-08-01)

Safety and efficacy of high-dose rifampicin in the management of tuberculosis meningitis: Systematic review and meta-analysis
by: Loveness Charlie, et al.
Published: (2021-01-01)

Repurposing 9-Aminoacridine as an Adjuvant Enhances the Antimicrobial Effects of Rifampin against Multidrug-Resistant Klebsiella pneumoniae
by: Pengfei She, et al.
Published: (2023-06-01)

Influence of Single Nucleotide Polymorphisms on Rifampin Pharmacokinetics in Tuberculosis Patients
by: Levin Thomas, et al.
Published: (2020-06-01)